The human gut microbiome in early-onset type 1 diabetes from the TEDDY study

Research output: Contribution to journalLetter

Abstract

Type 1 diabetes (T1D) is an autoimmune disease that targets pancreatic islet beta cells and incorporates genetic and environmental factors1, including complex genetic elements2, patient exposures3 and the gut microbiome4. Viral infections5 and broader gut dysbioses6 have been identified as potential causes or contributing factors; however, human studies have not yet identified microbial compositional or functional triggers that are predictive of islet autoimmunity or T1D. Here we analyse 10,913 metagenomes in stool samples from 783 mostly white, non-Hispanic children. The samples were collected monthly from three months of age until the clinical end point (islet autoimmunity or T1D) in the The Environmental Determinants of Diabetes in the Young (TEDDY) study, to characterize the natural history of the early gut microbiome in connection to islet autoimmunity, T1D diagnosis, and other common early life events such as antibiotic treatments and probiotics. The microbiomes of control children contained more genes that were related to fermentation and the biosynthesis of short-chain fatty acids, but these were not consistently associated with particular taxa across geographically diverse clinical centres, suggesting that microbial factors associated with T1D are taxonomically diffuse but functionally more coherent. When we investigated the broader establishment and development of the infant microbiome, both taxonomic and functional profiles were dynamic and highly individualized, and dominated in the first year of life by one of three largely exclusive Bifidobacterium species (B. bifidum, B. breve or B. longum) or by the phylum Proteobacteria. In particular, the strain-specific carriage of genes for the utilization of human milk oligosaccharide within a subset of B. longum was present specifically in breast-fed infants. These analyses of TEDDY gut metagenomes provide, to our knowledge, the largest and most detailed longitudinal functional profile of the developing gut microbiome in relation to islet autoimmunity, T1D and other early childhood events. Together with existing evidence from human cohorts7,8 and a T1D mouse model9, these data support the protective effects of short-chain fatty acids in early-onset human T1D.

Details

Authors
  • Tommi Vatanen
  • Eric A. Franzosa
  • Randall Schwager
  • Surya Tripathi
  • Timothy D. Arthur
  • Kendra Vehik
  • William A. Hagopian
  • Marian J. Rewers
  • Jin Xiong She
  • Jorma Toppari
  • Anette G. Ziegler
  • Beena Akolkar
  • Jeffrey P. Krischer
  • Christopher J. Stewart
  • Nadim J. Ajami
  • Joseph F. Petrosino
  • Dirk Gevers
  • Harri Lähdesmäki
  • Hera Vlamakis
  • Curtis Huttenhower
  • Ramnik J. Xavier
Organisations
External organisations
  • Broad Institute
  • Harvard University
  • University of South Florida
  • Pacific Northwest Diabetes Research Institute
  • University of Colorado
  • Augusta University
  • Turku University Hospital
  • University of Turku
  • Helmholtz Zentrum München
  • Klinikum rechts der Isar
  • Technical University of Munich
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Baylor College of Medicine
  • University of Newcastle upon Tyne
  • Massachusetts General Hospital
  • Massachusetts Institute of Technology
  • Skåne University Hospital
  • Janssen Research and Development
  • Aalto University
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Microbiology in the medical area
  • Endocrinology and Diabetes
Original languageEnglish
Pages (from-to)589-594
Number of pages6
JournalNature
Volume562
Issue number7728
Publication statusPublished - 2018
Publication categoryResearch
Peer-reviewedYes